JCP

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Leech, S N
Right arrow Articles by Leonard, N
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Leech, S N
Right arrow Articles by Leonard, N
Right arrowPubmed/NCBI databases
Medline Plus Health Information
*Lung Cancer
*Skin Cancer
J Clin Pathol 2001; 54:727-729
© 2001 Journal of Clinical Pathology


Short report

Merkel cell carcinoma can be distinguished from metastatic small cell carcinoma using antibodies to cytokeratin 20 and thyroid transcription factor 1

S N Leech, A J O Kolar, P D Barrett, S A Sinclair, N Leonard

Department of Dermatology, Dryburn Hospital, North Road, Durham DH1 5TW, UK
Department of Pathology, Dryburn Hospital
Department of Pathology, Royal Victoria Infirmary, University of Newcastle, Newcastle upon Tyne NE1 4LP, UK

Dr Leonard niamh.leonard{at}ncl.ac.uk Aim—To investigate whether immunohistochemical staining for cytokeratin 20 (CK20) and thyroid transcription factor 1 (TTF-1) is useful in distinguishing Merkel cell carcinomas (MCCs) from metastatic small cell carcinomas (SCCs).

Methods—Eleven cases of MCC and 10 of lung SCC were stained for CK20 and TTF-1.

Results—Ten of 11 MCCs stained with the antibody to CK20. None was positive for TTF-1. No SCC stained with anti-CK20 and all stained strongly with anti-TTF-1.

Conclusions—The use of both anti-CK20 and anti-TTF-1 can reliably distinguish between MCC and metastatic SCC, thus avoiding the need for a detailed clinical investigation of patients with MCC in whom metastatic SCC must be excluded.

Key Words: Merkel cell carcinoma • metastatic small cell carcinoma • cytokeratin 20 • thyroid transcription factor 1




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
Q. Zhou, M. Cadrin, H. Herrmann, C.-H. Chen, R. J. Chalkley, A. L. Burlingame, and M. B. Omary
Keratin 20 Serine 13 Phosphorylation Is a Stress and Intestinal Goblet Cell Marker
J. Biol. Chem., June 16, 2006; 281(24): 16453 - 16461.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
M. K. Tummala, P. F. Hausner, W. P. McGuire, T. Gipson, and A. Berkman
CASE 1. Testis: A Sanctuary Site in Merkel Cell Carcinoma
J. Clin. Oncol., February 20, 2006; 24(6): 1008 - 1009.
[Full Text] [PDF]


Home page
Arch DermatolHome page
A Large Friable Tumor Overlying the Left Side of the Mandible--Diagnosis
Arch Dermatol, May 1, 2004; 140(5): 609 - 614.
[Full Text] [PDF]


Home page
Mol. Biol. CellHome page
Q. Zhou, D. M. Toivola, N. Feng, H. B. Greenberg, W. W. Franke, and M. B. Omary
Keratin 20 Helps Maintain Intermediate Filament Organization in Intestinal Epithelia
Mol. Biol. Cell, July 1, 2003; 14(7): 2959 - 2971.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Journal of Clinical Pathology Molecular Pathology
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2001 by the BMJ Publishing Group Ltd & Association of Clinical Pathologists.